Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study.

Jiang Y, Owei I, Wan J, Ebenibo S, Dagogo-Jack S.

BMJ Open Diabetes Res Care. 2016 Mar 17;4(1):e000194. doi: 10.1136/bmjdrc-2016-000194. eCollection 2016.

2.

High serum adiponectin levels predict incident falls among middle-aged and older adults: a prospective cohort study.

Huang C, Momma H, Niu K, Chujo M, Otomo A, Cui Y, Nagatomi R.

Age Ageing. 2016 May;45(3):366-71. doi: 10.1093/ageing/afw043. Epub 2016 Mar 23.

3.

Plasma Adiponectin Levels in Elderly Patients with Prediabetes.

Kong SE, Kang YE, Joung KH, Lee JH, Kim HJ, Ku BJ.

Endocrinol Metab (Seoul). 2015 Sep;30(3):326-33. doi: 10.3803/EnM.2015.30.3.326. Epub 2015 Aug 4.

4.

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.

Almers LM, Graham JE, Havel PJ, Corley DA.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2256-64.e1-3. doi: 10.1016/j.cgh.2015.01.009. Epub 2015 Jan 26.

PMID:
25632808
5.

Adipokines as a novel link between obesity and atherosclerosis.

Yoo HJ, Choi KM.

World J Diabetes. 2014 Jun 15;5(3):357-63. doi: 10.4239/wjd.v5.i3.357. Review.

6.

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II.

Guo X, Zhou G, Guo M, Cheung AK, Huang Y, Beddhu S.

Physiol Rep. 2014 Feb 10;2(2):e00230. doi: 10.1002/phy2.230. eCollection 2014 Feb 1.

7.

Serum Levels of the Adipokine Zinc- α 2-glycoprotein Are Decreased in Patients with Hypertension.

Zhu HJ, Wang XQ, Pan H, Gong FY, Zhang DX, Li NS, Wang LJ, Yang HB.

ISRN Endocrinol. 2014 Feb 9;2014:374090. doi: 10.1155/2014/374090. eCollection 2014.

8.

Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris.

Choi KM, Hwang SY, Hong HC, Choi HY, Yoo HJ, Youn BS, Baik SH, Seo HS.

Cardiovasc Diabetol. 2014 Jan 13;13:14. doi: 10.1186/1475-2840-13-14.

9.

High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity?

Onat A, Aydın M, Can G, Köroğlu B, Karagöz A, Altay S.

World J Diabetes. 2013 Oct 15;4(5):219-25. doi: 10.4239/wjd.v4.i5.219.

10.

Association between adiponectin and heart failure risk in the physicians' health study.

Djoussé L, Wilk JB, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM.

Obesity (Silver Spring). 2013 Apr;21(4):831-4. doi: 10.1002/oby.20260.

11.

Adipocytokine associations with insulin resistance in british South asians.

Webb DR, Khunti K, Chatterjee S, Jarvis J, Davies MJ.

J Diabetes Res. 2013;2013:561016. doi: 10.1155/2013/561016. Epub 2013 Feb 25.

12.

Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery.

Hage MP, Safadi B, Salti I, Nasrallah M.

ISRN Endocrinol. 2012;2012:504756. doi: 10.5402/2012/504756. Epub 2012 May 7.

13.

Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction.

Woo YC, Tso AW, Xu A, Law LS, Fong CH, Lam TH, Lo SV, Wat NM, Cheung BM, Lam KS.

PLoS One. 2012;7(5):e36868. doi: 10.1371/journal.pone.0036868. Epub 2012 May 16.

14.

Previous gestational diabetes mellitus and markers of cardiovascular risk.

Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G.

Int J Endocrinol. 2012;2012:458610. doi: 10.1155/2012/458610. Epub 2012 Mar 18.

15.

Prevalence and anthropometric risk of metabolic syndrome in taiwanese adolescents.

Chu NF, Chin HC, Wang SC.

ISRN Cardiol. 2011;2011:743640. doi: 10.5402/2011/743640. Epub 2011 Jul 13.

16.

Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load.

Wolfson N, Gavish D, Matas Z, Boaz M, Shargorodsky M.

Exp Diabetes Res. 2012;2012:250621. doi: 10.1155/2012/250621. Epub 2011 Dec 27.

17.

Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population.

Kim SY, Lee SJ, Park HK, Yun JE, Lee M, Sung J, Jee SH.

Epidemiol Health. 2011;33:e2011007. doi: 10.4178/epih/e2011007. Epub 2011 Aug 20.

18.

Adiponectin pretreatment counteracts the detrimental effect of a diabetic environment on endothelial progenitors.

Leicht SF, Schwarz TM, Hermann PC, Seissler J, Aicher A, Heeschen C.

Diabetes. 2011 Feb;60(2):652-61. doi: 10.2337/db10-0240.

19.

High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study.

Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, Pereira M, Duncan BB, Schmidt MI.

J Clin Endocrinol Metab. 2010 Nov;95(11):5097-104. doi: 10.1210/jc.2010-0716. Epub 2010 Aug 18.

20.

Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.

Oliveira CR, Salvatori R, Meneguz-Moreno RA, Aguiar-Oliveira MH, Pereira RM, Valença EH, Araujo VP, Farias NT, Silveira DC, Vieira JG, Barreto-Filho JA.

J Clin Endocrinol Metab. 2010 Feb;95(2):693-8. doi: 10.1210/jc.2009-1919. Epub 2009 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk